Diabetes mellitus due to underlying condition
- E08 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM E08 became effective on October 1, 2024.
- This is the American ICD-10-CM version of E08 – other international versions of ICD-10 E08 may differ.
Use Additional
- code to identify control using:
- injectable non-insulin antidiabetic drugs (Z79.85)
- insulin (Z79.4)
- oral antidiabetic drugs (Z79.84)
- oral hypoglycemic drugs (Z79.84)
Code First
- the underlying condition, such as:
- congenital rubella (P35.0)
- Cushing’s syndrome (E24.-)
- cystic fibrosis (E84.-)
- malignant neoplasm (C00-C96)
- malnutrition (E40-E46 )
- pancreatitis and other diseases of the pancreas (K85-K86.-)
Type 1 Excludes
- drug or chemical induced diabetes mellitus (E09.-)
- gestational diabetes (O24.4-)
- neonatal diabetes mellitus (P70.2)
- postpancreatectomy diabetes mellitus (E13.-)
- postprocedural diabetes mellitus (E13.-)
- secondary diabetes mellitus NEC (E13.-)
- type 1 diabetes mellitus (E10.-)
- type 2 diabetes mellitus (E11.-)
The following code(s) above E08 contain annotation back-references
that may be applicable to E08:
- E00-E89 Endocrine, nutritional and metabolic diseases
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to E08:
- Type 1 Excludes: E09, E10, E11, E13
- Type 2 Excludes: R11.15, E87.0
- Use Additional: O24.8, O24.9